Stay updated with breaking news from Base Sweden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During a time period with improvements in treatment of advanced prostate cancer, there was a simultaneous clinically meaningful increase in mean survival for men with de novo metastatic castration-sensitive prostate cancer (mCSPC).
Shift in survival occurred during introduction of doublet therapy
THURSDAY, Oct. 19, 2023 (HealthDay News) -- During a time period with improvements in treatment of advanced prostate cancer, there was a simultaneous clinically meaningful increase in mean survival for men with de novo metastatic castration-sensitive prostate cancer (mCSPC), according to a study published online Oct. 2 in JAMA Network Open. Christian Corsini, M.D., from
THURSDAY, Oct. 19, 2023 (HealthDay News) -- During a time period with improvements in treatment of advanced prostate cancer, there was a simultaneous clinically meaningful increase in mean survival for
Researchers assessed 30-year trajectories of prostate cancer in men with very low- to intermediate-risk prostate cancer on active surveillance.